Berberine efficacy against Doxorubicin-induced cardiotoxicity: A systematic review
Open Access
- 18 March 2023
- journal article
- review article
- Published by Maad Rayan Publishing Company in Journal of Herbmed Pharmacology
- Vol. 12 (2) , 187-193
Abstract
Cardiotoxicity is one of the main complications of chemotherapy that increases morbidity and mortality in cancerous patients. The present systematic review aimed to investigate the protective effects of berberine (Ber) on doxorubicin (Dox)-induced cardiotoxicity. The study protocol was developed following the PRISMA statement. An extensive search was performed in multiple databases, including Embase, PubMed, Cochrane library, Web of Science, and Scopus. After defining the inclusion/exclusion criteria of the study, 12 records were included. The desired data of the retrieved articles were extracted from the studies and imported into an Excel form and ultimately, the effects, probable outcomes and mechanisms were surveyed. By activating sirtuin 1 (SIRT1), Ber caused reduced oxidative damage and loss of mitochondria integrity in cardiomyocytes. It also regulated autophagy and apoptosis via down-regulating AMP-activated protein kinase (AMPK), nucleotide-binding oligomerization domain, leucine rich repeat, and pyrin domain containing protein (NLRP) activation. Moreover, Ber increased superoxide dismutase (SOD), catalase (CAT), and plasma glutathione peroxidase (GSH-Px) activities, reduced the levels of malondialdehyde (MDA), up-regulated SIRT3, and subsequently reduced oxidative stress in cardiomyocytes and loss of mitochondria integrity, leading to developed apoptosis and regulating the histopathological and electrocardiogram changes in the myocardium. It also ameliorated the DOX-induced calcium ions (Ca2+) and iron overload. Ber reduced oxidant and inflammatory activity, and regulated apoptosis of cardiomyocytes, thus protecting the cells against DOX-induced cardiotoxicity.Keywords
This publication has 46 references indexed in Scilit:
- Assessment of the Relationship Between Gastric-Acid Suppressants and the Risk of Esophageal Adenocarcinoma: A Systematic Review and Meta-AnalysisCurrent Therapeutic Research, 2023
- Cardiotoxicity linked to anticancer agents and cardioprotective strategyArchives of Pharmacal Research, 2022
- Ferroptosis and its role in cardiomyopathyBiomedicine & Pharmacotherapy, 2022
- Serum levels of IL-32 in patients with coronary artery disease and its relationship with the serum levels of IL-6 and TNF-αMolecular Biology Reports, 2021
- Combined effects of berberine and evodiamine on colorectal cancer cells and cardiomyocytes in vitroEuropean Journal of Pharmacology, 2020
- Ratiometric delivery of doxorubicin and berberine by liposome enables superior therapeutic index than DoxilⓇAsian Journal of Pharmaceutical Sciences, 2020
- Nano strategies for berberine delivery, a natural alkaloid of BerberisBiomedicine & Pharmacotherapy, 2018
- Hepatoprotective effects of berberine on acetaminophen-induced hepatotoxicity in miceBiomedicine & Pharmacotherapy, 2018
- Berberine-induced cardioprotection and Sirt3 modulation in doxorubicin-treated H9c2 cardiomyoblastsBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2017
- The enhancement of cardiac toxicity by concomitant administration of Berberine and macrolidesEuropean Journal of Pharmaceutical Sciences, 2015